Clinical Trials

A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation


Study ID
Alliance A071102

NCT Number
NCT02152982 (Click on the NCT number for more information about the trial)

Research Study Number
00005495

Principle Investigator
Dr. Samuel Goldlust

Phase
II/III

Sponsor
Alliance


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now